Patent · US Active

Engineered DNA polymerase variants

US12018295B2 · kind B2 · utility

0Cited by
133References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 11, 2021
Grant dateJun 25, 2024
Priority date
Expiry dateJan 6, 2042

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/9126
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention provides engineered DNA polymerase polypeptides and compositions thereof, as well as polynucleotides encoding the engineered DNA polymerase polypeptides. The invention also provides methods for use of the compositions comprising the engineered DNA polymerase polypeptides for diagnostic and other purposes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.